These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25895046)

  • 21. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
    Yazaki P; Lwin T; Minnix M; Li L; Sherman A; Molnar J; Miller A; Frankel P; Chea J; Poku E; Bowles N; Hoffman R; Shively J; Bouvet M
    J Biomed Opt; 2019 Jun; 24(6):1-9. PubMed ID: 31254333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.
    Hoogstins CES; Boogerd LSF; Sibinga Mulder BG; Mieog JSD; Swijnenburg RJ; van de Velde CJH; Farina Sarasqueta A; Bonsing BA; Framery B; Pèlegrin A; Gutowski M; Cailler F; Burggraaf J; Vahrmeijer AL
    Ann Surg Oncol; 2018 Oct; 25(11):3350-3357. PubMed ID: 30051369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody.
    Rijpkema M; Oyen WJ; Bos D; Franssen GM; Goldenberg DM; Boerman OC
    J Nucl Med; 2014 Sep; 55(9):1519-24. PubMed ID: 24982436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
    Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
    Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein Receptor CEACAM5-Targeted Intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer.
    Azari F; Kennedy GT; Chang A; Bernstein E; Nadeem B; Pèlegrin A; Cailler F; Sullivan NT; Kucharczuk J; Singhal S
    Ann Thorac Surg; 2023 Sep; 116(3):631-641. PubMed ID: 35644263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
    Bouvet M; Hoffman RM
    Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
    Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW.
    Boss M; Bos D; Frielink C; Sandker G; Ekim S; Marciniak C; Pattou F; van Dam G; van Lith S; Brom M; Gotthardt M; Buitinga M
    J Nucl Med; 2020 Jul; 61(7):1066-1071. PubMed ID: 31924726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
    Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.
    Lisy MR; Goermar A; Thomas C; Pauli J; Resch-Genger U; Kaiser WA; Hilger I
    Radiology; 2008 Jun; 247(3):779-87. PubMed ID: 18413884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery.
    Han Z; Shang W; Liang X; Yan H; Hu M; Peng L; Jiang H; Fang C; Wang K; Tian J
    Mol Imaging Biol; 2019 Feb; 21(1):67-77. PubMed ID: 29858735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.
    Lütje S; Rijpkema M; Goldenberg DM; van Rij CM; Sharkey RM; McBride WJ; Franssen GM; Frielink C; Helfrich W; Oyen WJ; Boerman OC
    Cancer Res; 2014 Nov; 74(21):6216-23. PubMed ID: 25252911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
    de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
    Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
    J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
    Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
    PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
    Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
    Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.